Experts Convene in Nashville at Psych Congress 2023 to Address Rising Concerns in MDD Treatment

Psych Congress will celebrate 36 years of delivering practical, case-based education to psychiatrists, nurse practitioners, physician assistants, and other mental health professionals, from September 6-10 in Nashville, Tennessee. 

The National Institute of Mental Health reported that, in 2021, 8.3% of US adults had experienced at least 1 major depressive episode. This was more common in women and young people. The World Health Organization (WHO) has even predicted that, by 2030, MDD will rank as the first cause of the burden of disease worldwide. 

Psych Congress promises to equip clinicians and other mental health professionals with the tools and clinical pearls to better work with their patients with MDD and other related depressive disorders. 

In the keynote address, “Eric C. Arauz Memorial Keynote Address: Healing through Music: The Transformative Power of Songwriting in Mental Health,” developed in partnership with the American Foundation for Suicide Prevention (AFSP), local Nashville musicians will share personal stories and perform songs that have helped them to heal and explore how music can provide a cathartic release, self-expression, and emotional processing. 

On Thursday, Greg Mattingly, MD, president of Midwest Research Group, and Leslie Citrome, MD, MPH, clinical professor at New York Medical College, will present “Atypical Antipsychotics for Adjunctive Treatment of MDD: Advancing the Standard of Care.” In this session, Mattingly and Citrome will explore the burden and unmet needs associated with MDD, with a special focus on patients who exhibit inadequate or partial responses to antidepressant monotherapy. Attendees will learn how to confidently tailor appropriate adjunctive treatments for patients facing inadequate or partial responses to antidepressant therapy.

On Saturday, William McCall, MD, MS, case distinguished university chair of psychiatry, Medical College of Georgia at Augusta University, will examine the latest advances in neuromodulation techniques, including deep brain stimulation, transcranial magnetic stimulation, and transcranial direct current stimulation in his session “Advances in Neuromodulation and Stimulation for the Treatment of Major Depressive Disorder.” Attendees will learn about the safety and efficacy of these techniques, as well as the potential advantages and limitations of each approach.

To keep up with the latest news and live coverage, check out the Psych Congress Newsroom.